Artemisia annuaL. extracts inhibit thein vitroreplication of SARS-CoV-2 and two of its variants
Open Access
- 8 January 2021
- preprint content
- research article
- Published by Cold Spring Harbor Laboratory in Biorxiv
Abstract
SARS-CoV-2 (Covid-19) globally has infected and killed millions of people. Besides remdesivir, there are no approved small molecule-based therapeutics. Here we show that extracts of the medicinal plant, Artemisia annua L., which produces the antimalarial drug artemisinin, prevents SARS-CoV-2 replication in vitro. We measured antiviral activity of dried leaf extracts of seven cultivars of A. annua sourced from four continents. Hot-water leaf extracts based on artemisinin, total flavonoids, or dry leaf mass showed antiviral activity with IC50 values of 0.1-8.7 μM, 0.01-0.14 μg, and 23.4-57.4 μg, respectively. One sample was >12 years old, but still active. While all hot water extracts were effective, concentrations of artemisinin and total flavonoids varied by nearly 100-fold in the extracts and antiviral efficacy was inversely correlated to artemisinin and total flavonoid contents. Artemisinin alone showed an estimated IC50 of about 70 μM, and antimalarial artemisinin derivatives artesunate, artemether, and dihydroartemisinin were ineffective or cytotoxic at elevated micromolar concentrations. In contrast, the antimalarial drug amodiaquine had an IC50 = 5.8 μM. The extracts had minimal effects on infection of Vero E6 or Calu-3 cells by a reporter virus pseudotyped by the SARS-CoV-2 spike protein. There was no cytotoxicity within an order of magnitude of the antiviral IC90 values. Results suggest the active component in the extracts is likely something besides artemisinin or is a combination of components acting synergistically to block post-entry viral infection. Further studies will determine in vivo efficacy to assess whether A. annua might provide a cost-effective therapeutic to treat SARS-CoV-2 infections.Keywords
This publication has 37 references indexed in Scilit:
- Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its DerivativesMediators of Inflammation, 2015
- Variations in key artemisinic and other metabolites throughout plant development in Artemisia annua L. for potential therapeutic useIndustrial Crops and Products, 2015
- An extract of the medicinal plant Artemisia annua modulates production of inflammatory markers in activated neutrophilsJournal of Inflammation Research, 2015
- Changes in key constituents of clonally propagated Artemisia annua L. during preparation of compressed leaf tablets for possible therapeutic useIndustrial Crops and Products, 2014
- Pharmacokinetics of artemisinin delivered by oral consumption of Artemisia annua dried leaves in healthy vs. Plasmodium chabaudi-infected miceJournal of Ethnopharmacology, 2014
- Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccinesJournal of Virological Methods, 2010
- Automated minimization of steric clashes in protein structuresProteins, 2010
- Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseasesPhytochemistry Reviews, 2010
- The history of qing hao in the Chinese materia medicaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Identification of natural compounds with antiviral activities against SARS-associated coronavirusAntiviral Research, 2005